MS Speaks
Multiple Sclerosis => TREATMENTS => Topic started by: agate on December 14, 2019, 04:59:16 pm
-
This is a small study (30 patients) but the finding that some patients had amenorrhea lasting more than 12 months and ovarian failure would be a concern.
From PubMed (December 14, 2019), "Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway":
https://www.ncbi.nlm.nih.gov/pubmed/31833798